OUR COMMITMENT TO RESEARCH
As a community of longevity experts, doctors, and scholars, AgelessRx is fully committed to the invaluable role research plays in medicine and the limitless opportunities it presents for the future.
In that spirit, AgelessRx is proud to play a leading role in discovering new, scientifically-proven treatment options that prevent age-related diseases and reverse age-related damage.
CURRENT RESEARCH PROJECTS
Participatory Evaluation of Aging with Rapamycin for Longevity (PEARL)
Rapamycin is an FDA-approved antifungal agent, most used to prevent organ transplant rejection. Rapamycin targets the mTOR signaling pathway, which is associated with many aging-related diseases.
PEARL is a double-blind, randomized, placebo-controlled trial. Notably, it is the first nationwide telemedicine trial and the first large-scale intervention trial on longevity. PEARL is proudly sponsored by AgelessRx and affiliated with the University of California.